Delayed cardioprotection in a human cardiomyocyte-derived cell line: The role of adenosine, p38MAP kinase and mitochondrial K(ATP)

Basic Research in Cardiology

Volumn 95, Issue 3, 2000, Pages 243-249

  Carroll, Richard ^a   Yellon, Derek M ^a  

^a UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Adenosine; Hypoxia reoxygenation; Mitochondrial K(ATP); Preconditioning

Indexed keywords

5 HYDROXYDECANOIC ACID; ADENOSINE; ADENOSINE TRIPHOSPHATE; LACTATE DEHYDROGENASE; MITOGEN ACTIVATED PROTEIN KINASE; POTASSIUM CHANNEL; PROPIDIUM IODIDE;

ARTICLE; CELL LINE; CONTROLLED STUDY; HEART MITOCHONDRION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; HUMAN CELL; MITOCHONDRIAL RESPIRATION;

ADENOSINE; CELL LINE; DECANOIC ACIDS; HEART; HUMANS; HYDROXY ACIDS; IMIDAZOLES; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MEMBRANE PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASES; MYOCARDIUM; P38 MITOGEN-ACTIVATED PROTEIN KINASES; POTASSIUM CHANNELS; PYRIDINES; TIME FACTORS;

EID: 0034128523     PISSN: 03008428     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003950050187     Document Type: Article

References (46)

1. Baxter GF, Marber MS, Patel VC, Yellon DM (1994) Adenosine receptor involvement in a delayed phase of myocardial protection 24 hours after ischemic preconditioning. Circulation 90: 2993-3000
2. Bogoyevitch MA, Gillespie Brown J, Ketterman AJ, Fuller SJ, Ben Levy R, Ashworth A, Marshall CJ, Sugden PH (1996) Stimulation of the stress-activated mitogen-activated protein kinase subfamilies in perfused heart. p38/RK mitogen-activated protein kinases and c-Jun N-terminal kinases are activated by ischemia/reperfusion. Circ Res 79: 162-173
3. Borchgrevink PC, Ryan MP (1988) Effects of magnesium, ouabain and bumetanide on 86-rubidium uptake in a human atrial cell line. Br J Pharmacol 95: 614-618
4. Carr CS, Hill RJ, Masumune H, Kennedy SP, Knight DR, Tracey WR, Yellon DM (1997) Evidence for a role for both the adenosine A1 and A3 receptors in protection of isolated human atrial muscle against simulated ischaemia. Cardiovasc Res 36: 52-59
5. Cordeiro JM, Ferrier GR, Howlett SE (1995) Effects of adenosine in simulated ischemia and reperfusion in guinea pig ventricular myocytes. Am J Physiol 269: H121-H129
6. Cuenda A, Rouse J, Doza YN, Meier R, Cohen P, Gallagher TF, Young PR, Lee JC (1995) SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett 364: 229-233
7. Dana A, Baxter GF, Walker JM, Yellon DM (1998) Prolonging the delayed phase of myocardial protection: repetitive adenosine Al receptor activation maintains rabbit myocardium in a preconditioned state [see comments]. J Am Coll Cardiol 31: 1142-1149
8. Dana A, Yellon DM (1999) Adenosine A1 receptor induced delayed cardioprotection: investigation into time course and cellular mechanisms. Heart (abstract)
9. Das DK, Maulik N, Yoshida T, Engelman RM, Zu Y (1997) Tyrosine kinase P38 MAP kinases-mapkap kinase-2 signalling in ischaemic preconditioning leads to the transcription of Hsp27 and Hsp70: a mechanism for second window of protection. Abstract Submitted
10. Ergul A, Tackett RL, Puett D (1995) Identification of receptor binding and activation sites in endothelin-1 by use of site-directed mutagenesis. Circ Res 77: 1087-1094
11. Esumi K, Nishida M, Shaw D, Smith TW, Marsh JD (1991) NADH measurements in adult rat myocytes during simulated ischaemia. Am J Physiol 260: H1743-H1752
12. Garlid KD, Paucek P, Yarov-Yarovoy V, Murray HN, Darbenzio RB, AJ DA, Lodge NJ, Smith MA, Graver GJ (1997) Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels. Possible mechanism of cardioprotection. Circ Res 81: 1072-1082
13. Gerwins P, Fredholm BB (1995) Activation of adenosine A1 and bradykinin receptors increases protein kinase C and phospholipase D activity in smooth muscle cells. Naunyn Schmiedebergs Arch Pharmacol 351: 186-193
14. Gross GJ, Fryer RM (1999) Sarcolemmal versus mitochondrial ATP-sensitive K+ channels and myocardial preconditioning. Circ Res 84: 973-979
15. Grover GJ (1997) Pharmacology of ATP-sensitive potassium channel openers in models of myocardial ischaemia and reperfusion. Can J Physiol Pharmacol 75: 309-315
16. Grover GJ, AJ DA, Dzwonczyk S, Parham CS, Darbenzio RB (1996) Preconditioning is not abolished by the delayed rectifier K+ blocker dofetilide. Am J Physiol 271: H1207-H1214
17. Haq SE, Clerk A, Sugden PH (1998) Activation of mitogen-activated protein kinases (p38-M APKs, SAPKs/JNKs and ERKs) by adenosine in the perfused rat heart. FEBS Lett 434: 305-308
18. Heads RJ, Latchman DS, Yellon DM (1994) Differences in the ability of transfected HSP70 and HSP90 genes to protect H9c2 myocytes against heat stress and hypoxia. Circulation 90 (suppl): 1-536 (abstract)
19. Hill RJ, Oleynek JJ, Magee W, Knight DR, Tracey WR (1998) Relative importance of adenosine A1 and A3 receptors in mediating physiological or pharmacological protection from ischemic myocardial injury in the rabbit heart. J Mol Cell Cardiol 30: 579-585
20. Holmuhamedov EL, Jovanovic S, Dzeja PP, Jovanovic A, Terzic A (1998) Mitochondrial ATP-sensitive K+ channels modulate cardiac mitochondrial function. Am J Physiol 275: H1567-H1576
21. Ikonomidis JS, Toshizumi S, Weisel RD, Derylo B, Rao V, Whiteside CI, Mickle DAG, Li R (1997) Preconditioning cultured human pediatric myocytes requires adenosine and protein kinase C. Am J Physiol 272: H1220-H1230
22. Ishikawa K, Ihara M, Noguchi K, Mase T, Mino N, Saeki T, Fukuroda T, Fukami T, Ozaki S, Nagase T et al. (1994) Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788. Proc Natl Acad Sci USA 91: 4892-4896
23. Kloner RA, Shook T, Amman EM, Cannon CP, Przyklenk K, Yoo K, McCabe CH, Braunwald E (1998) Prospective temporal analysis of the onset of preinfarction angina versus outcome: an ancillary study in TIMI-9B. Circulation 97: 1042-1045
24. Kuzuya T, Hoshida S, Yamashita N, Fuji H, Oe H, Hori M, Kamada T, Tada M (1993) Delayed effects of sublethal ischemia on the acquisition of tolerance to ischemia. Circ Res 72: 1293-1299
25. Lamb JF, McCall D (1971) Uptake of (3H)ouabain and Na pump turnover rates in monolayer cultures of Girardi heart cells. J Physiol (Lond) 213: 57P-58P
26. Liu Y, Gao WD, B OR, Marban E (1996) Synergistic modulation of ATP-sensitive K+ currents by protein kinase C and adenosine. Implications for ischemic preconditioning. Circ Res 78: 443-454
27. Liu Y, Sato T, B OR, Marban E (1998) Mitochondrial ATP-dependent potassium channels: novel effectors of cardioprotection? Circulation 97: 2463-2469
28. Marber MS, Latchman DS, Walker JM, Yellon DM (1993) Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction. Circulation 88: 1264-1272
29. Maulik N, Watanabe M, Zu YL, Huang CK, Cordis GA, Schley JA, Das DK (1996) Ischemic preconditioning triggers the activation of MAP kinases and MAPKAP kinase 2 in rat hearts. FEBS Lett 396: 233-237
30. McCullough JR, Normandin DE, Conder ML, Sleph PG, Dzwonczyk S, Grover GJ (1991) Specific block of the anti-ischemic actions of cromakalim by sodium 5-hydroxydecanoate. Circ Res 69: 949-958
31. Mihara S, Fujimoto M (1992) Non-isopep-tide-selective endothelin receptors in human Girardi heart cells. Life Sci 50: 219-226
32. Mullane K, Bullough D (1995) Harnessing an endogenous cardioprotective mechanism: cellular sources and sites of action of adenosine. J Mol Cell Cardiol 27: 1041-1054
33. Murry CE, Jennings RB, Reimer KA (1986) Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74: 1124-1136
34. Nagarkatti DS, Sha'afi RI (1998) Role of p38MAP kinase in myocardial stress. J Mol Cell Cardiol 30: 1651-1664
35. Randall MD, Ujiie H, Griffith TM (1994) Modulation of vasodilatation to levcromakalim by adenosine analogues in the rabbit ear: an explanation for hypoxic augmentation. Br J Pharmacol 112: 49-54
36. Rouslin W (1991) Regulation of the mitochondrial ATPase in situ in cardiac muscle: role of the inhibitor subunit. J Bioenerg Biomemb. 23: 873-888
37. Sawmiller DR, Fenton RA, Dobson JR (1998) Myocardial adenosine A1-receptor sensitivity during juvenile and adult stages of maturation. Am J Physiol 274: H627-H635
38. Speechly Dick ME, Grover GJ, Yellon DM (1995) Does ischemic preconditioning in the human involve protein kinase C and the ATP-dependent K+ channel? Studies of contractile function after simulated ischemia in an atrial in vitro model. Circ Res 77: 1030-1035
39. Sumeray M, Yellon D (1997) Myocardial preconditioning. What have we learned? Eur Heart J 18: A8-A14
40. 1 adenosine receptor blockade by bamiphylline on ischaemic preconditioning during coronary angioplasty. Eur Heart J 17: 846-853
41. Weinbrenner C, Liu GS, Cohen MV, Downey JM (1997) Phosphorylation of tyrosine 182 of P38 mitogen-activated protein kinase correlates with the protection of preconditioning in the rabbit heart. J Molec Cell Cardiol 29: 2383-2391
42. Werdan K, Bauriedel G, Fischer B, Krawietz W, Erdmann E, Schmitz W, Scholz H (1982) Stimulatory (insulin-mimetic) and inhibitory (ouabain-like) action of vanadate on potassium uptake and cellular sodium and potassium in heart cells in culture. Biochim Biophys Acta 687: 79-93
43. Woolfson RG, Patel VC, Yellon DM (1996) Pre-conditioning with adenosine leads to concentration-dependent infarct size reduction in the isolated rabbit heart. Cardiovasc Res 31: 148-151
44. Yao Z, Mizumura T, Mei DA, Gross GJ (1997) KATP channels and memory of ischemic preconditioning in dogs: synergism between adenosine and KATP channels. Am J Physiol 272: H334-H342
45. Yellon DM, Alkhulaifi AM, Pugsley WB (1993) Preconditioning the human myocardium. Lancet 342: 276-277
46. Yellon DM, Baxter GF (1995) A "second window of protection" or delayed preconditioning phenomenon: future horizons for myocardial protection? J Mol Cell Cardiol 27: 1023-1034